Telomir PharmaceuticalsTELO
13F holders, Q1 2024 (March 31)7holders
$5.17avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Telomir Pharmaceuticals Inc. (TELO) in their 13F filings. The largest holders were Suncoast Equity Management ($126K), Citigroup Inc. ($93K) and Lido Advisors, LLC ($77K).
- Company
- Telomir Pharmaceuticals Inc.
- CUSIP
- 87975F104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $413K |
| Exits | 0 | $0 |
Ownership 7 holders
| Suncoast Equity Management | 0.01% | New | 24,391 | $126K |
| Citigroup Inc. | 0.00% | New | 17,748 | $93K |
| Lido Advisors, LLC | 0.00% | New | 15,000 | $77K |
| FNY Investment Advisers, LLC | 0.05% | New | 14,900 | $77K |
| Beaird Harris Wealth Management, LLC | 0.00% | New | 4,673 | $24K |
| JPMorgan Chase & Co. | 0.00% | New | 2,605 | $14K |
| Osaic Holdings, Inc. | 0.00% | New | 600 | $3K |
"% of holder's portfolio" is TELO's weight in each manager's 13F, not the share of Telomir Pharmaceuticals Inc. the manager owns.